Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner
Crossref DOI link: https://doi.org/10.1038/cddis.2015.129
Published Online: 2015-05-14
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Werthmöller, N
Frey, B
Wunderlich, R
Fietkau, R
Gaipl, U S
Text and Data Mining valid from 2015-05-14
Version of Record valid from 2015-05-14
Article History
Received: 22 December 2014
Revised: 17 March 2015
Accepted: 6 April 2015
First Online: 14 May 2015
Competing interests
: The authors declare no conflict of interest.